Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Sarawgi

What Are Wall Street Analysts' Target Price for Zoetis Stock?

Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, and commercializes animal health medicines, vaccines, and diagnostic products and services. With a market cap of $79.9 billion, Zoetis’ operations span over 100 countries in North America, Europe, and internationally.

The animal health giant has significantly underperformed the broader market over the past year. ZTS stock has declined 10.3% on a YTD basis and gained 4.9% over the past 52 weeks lagging behind the S&P 500 Index’s ($SPX) rally of 25.5% in 2024 and 35.7% over the past 52-week period.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.